Treatment of Colitis with Constipation
For colitis with constipation, the recommended first-line treatment is a combination of topical mesalazine 1 g daily with oral mesalazine 2-4 g daily, plus stool bulking agents or laxatives to address the proximal constipation. 1, 2
Understanding Colitis with Constipation
- Proximal constipation can paradoxically worsen diarrhea symptoms in distal ulcerative colitis (UC) and requires specific management 2
- This condition is sometimes referred to as "ulcerative colitis-associated constipation syndrome" or "proximal constipation" and is particularly common in patients with left-sided colitis 3
- It occurs in approximately 46% of UC patients, with higher prevalence in women and those with active distal disease 3
Treatment Algorithm Based on Disease Extent and Severity
For Distal Colitis with Constipation:
First-line therapy:
Second-line therapy:
For inadequate response:
For Extensive Colitis with Constipation:
- Oral mesalazine 2-4 g daily or balsalazide 6.75 g daily as first-line therapy 2
- Prednisolone 40 mg daily when prompt response is required or mesalazine has been unsuccessful 2
- Address constipation with appropriate laxatives or stool bulking agents 1, 3
Management of Severe Disease
- Hospitalization is required for severe colitis with:
Special Considerations for Crohn's Disease with Constipation
- For mild ileocolonic Crohn's disease, high-dose mesalazine (4 g/daily) may be sufficient initial therapy 1
- For moderate to severe disease, oral corticosteroids such as prednisolone 40 mg daily is appropriate 1
- Address constipation with appropriate laxative therapy 1
Important Considerations and Pitfalls
- Always exclude infectious causes of diarrhea before attributing symptoms to UC flare and escalating therapy 2, 4
- Combination therapy (topical plus oral) is more effective than either treatment alone for controlling symptoms in distal disease 2
- Rapid steroid tapering is associated with early relapse and should be avoided; generally, prednisolone should be tapered over 8 weeks 1, 2
- Lifelong maintenance therapy is generally recommended for all patients to prevent recurrent episodes, especially for those with left-sided or extensive disease 2, 4
- Patients with persistent symptoms despite optimized therapy may require consideration of alternative diagnoses or treatment escalation 4
Long-term Management
- Azathioprine 1.5-2.5 mg/kg/day or mercaptopurine 0.75-1.5 mg/kg/day may be used as maintenance therapy for patients with chronic active steroid-dependent disease 2, 4
- Regular follow-up is essential to monitor disease activity and treatment response 4
- Surgery should be considered for those who have failed medical therapy 1